Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
International Psychogeriatrics|March 10, 2007
Clinical and economic outcomes--friend or foe?Anders WimoDrugs & Aging|March 26, 2004
Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerationsAnders WimoJournal of Alzheimer'S Disease : JAD|May 2, 2018
The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's ViewAnders WimoExpert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Pharmacoeconomic aspects of memantine (Ebixa) in the treatment of Alzheimer's diseaseAnders WimoActa Neurologica Scandinavica. Supplementum|February 27, 2003
Pharmacoeconomics of mild cognitive impairmentAnders Wimo, Bengt WinbladArchives of Gerontology and Geriatrics|June 17, 2006
Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrumentAnders Wimo, Gunilla NordbergInternational Journal of Cardiology|March 4, 2020
Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adultsPeter Magnusson, Anders WimoPharmacoeconomics|July 10, 2009
The cost of dementia in Europe: a review of the evidence, and methodological considerationsLinus Jönsson, Anders WimoAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cost-effectiveness studiesAnders Wimo, Anders NorlundPageof 17